Other

Anti-obesity drugs fatten Novo Nordisk profits

Danish drugmaker Novo Nordisk reported Thursday a sharp rise in third quarter sales and profits driven by the success of its anti-diabetes and anti-obesity treatments Ozempic and Wegovy.

Radiology & Imaging

Special probes improve ultrasound imaging in obese patients

Ultrasound is used to diagnose many diseases in the abdominal cavity. A new study conducted at the University of Leipzig Medical Center and supported by the Helmholtz Institute for Metabolism, Obesity and Vascular Research ...

page 31 from 40